Improved bioavailability of orally administered andrographolide from pH-sensitive nanoparticles
- 30 December 2010
- journal article
- research article
- Published by Springer Nature in European Journal of Drug Metabolism and Pharmacokinetics
- Vol. 35 (3-4) , 123-129
Abstract
Andrographolide, a major bioactive phytoconstituent derived from Androgaphis paniculata that is safe and beneficial in several ailments, was formulated into pH-sensitive nanoparticle suspension with a view of improving its oral bioavailability. The andrographolide-loaded pH-sensitive nanoparticles were prepared by nanoprecipitation technique using Eudragit® EPO (cationic poly methacrylate copolymer). The 32 factorial design was used to optimize the amount of polymer and stabilizer (Pluronic® F-68). The optimized batch obtained using 0.45% w/v of Eudragit® EPO and 0.6% w/v of Pluronic® F-68 showed high-encapsulation efficiency of 93.8 ± 0.67% with particle size of 255 ± 9 nm and zeta potential of 29.3 ± 3.4 mV. The bioavailability of andrographolide from optimized nanoparticles and pure andrographolide was assessed in male Wistar albino rats at a dose of 10 mg/kg. As compared to the pure andrographolide, almost 2.2 and 3.2-fold increase in AUC0–∞, C max and 121.53% increase in relative bioavailability were observed for andrographolide from pH-sensitive nanoparticles (P < 0.05). Shorter T max by about fourfold difference were observed with 2.2-fold decrease in Cl/F. The improved dissolution rate owing to its reduced particle size, increased surface area and reduced diffusion layer thickness may have contributed to oral bioavailability. The results clearly indicate the potential of pH-sensitive nanoparticles for oral delivery of low-bioavailability phytoconstituents such as andrographolide.Keywords
This publication has 25 references indexed in Scilit:
- Eudragit® EPO Based Nanoparticle Suspension of Andrographolide: In Vitro and In VivoNanoscience and Nanotechnology Letters, 2009
- Evaluation of molecular pharmaceutical and in-vivo properties of spray-dried isolated andrographolide—PVPJournal of Pharmacy and Pharmacology, 2009
- Evaluation of molecular pharmaceutical and in-vivo properties of spray-dried isolated andrographolide-PVPJournal of Pharmacy and Pharmacology, 2009
- Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugsInternational Journal of Pharmaceutics, 2006
- Oral evaluation in rabbits of cyclosporin-loaded Eudragit RS or RL nanoparticlesInternational Journal of Pharmaceutics, 2005
- In Vitro and In Vivo Evaluation of Oral Heparin–Loaded Polymeric Nanoparticles in RabbitsCirculation, 2002
- Pharmacokinetic and oral bioavailability of andrographolide from Andrographis paniculata fixed combination Kan Jang in rats and humanPhytomedicine, 2000
- Targeting of Liposomal Andrographolide toL.donovani-Infected Macrophages in VivoDrug Delivery, 2000
- Cell Differentiation-Inducing Diterpenes from Andrographis paniculata NEES.Chemical and Pharmaceutical Bulletin, 1994
- Enteral insulin delivery by microspheres in 3 different formulations using Eudragit L100 and S100International Journal of Pharmaceutics, 1993